119 JCPenney stores sold in nearly $1 billion deal, including 6 in Florida
A Boston private equity firm will pay $947 million for 119 JCPenney stores, including six in Florida.
The all-cash sale of 119 JCPenney properties to an affiliate of Onyx Partners, Ltd. was announced by Copper Property CTL Pass Through Trust July 25. The transaction is scheduled to close on or before Sept. 8.
In February, JCPenney announced eight locations would be closed this year, adding to the list of more than 200 closures planned. No Florida stores were on the list.
Here's what to know.
Why is JCPenney closing stores?
JCPenney filed for Chapter 11 bankruptcy protection in May 2020. At the time, the company said it would close more than 200 locations across the country.
The chain was later acquired by Simon Property Group and Brookfield Asset Management Inc. in December 2020. In January 2025, JCPenney said it had partnered with Forever 21 to create a new company called Catalyst Brands.
The department store chain, which currently has about 650 stores, was one of the largest retailers to file for Chapter 11 bankruptcy protection.
Will the 119 JCPenney stores sold remain open?
All 119 stores — including six in Florida — that were sold are currently open for business.
The buyer, Onyx Partners, did not respond to a request for comment from USA TODAY.
Which JCPenney stores in Florida, US are being sold?
Map shows JCPenney stores sold in Florida
Among the 119 stores sold were six in Florida, located in:
Brandon
Clearwater
Panama City Beach
Pembroke Pines
Plantation
Wellington
How many JCPenney stores are left in Florida?
According to JCPenney's website, there are 44 stores open in Florida in the following cities:
Altamonte Springs
Aventura
Boynton Beach
Brandon
Clearwater
Clermont
Coral Springs
Davenport
Daytona Beach
Fort Myers
Gainesville
Hialeah
Jacksonville
Jensen Beach
Kissimmee
Lake City
Lakeland
Melbourne
Merritt Island
Miami - 3
Naples
Ocala
Ocoee
Orange Park
Orlando
Panama City
Panama City Beach
Pembroke Pines
Pensacola
Plantation
Pompano Beach
Port Charlotte
St. Petersburg
Sanford
Sarasota
Spring Hill
Tallahassee
Tampa - 2
Vero Beach
Wellington
What is Copper Property CTL?
Copper Property CTL Pass Through Trust was established to acquire 160 retail properties and six warehouse distribution centers from JCPenney as part of its Chapter 11 plan of reorganization.
Contributing: Mike Snider, Sara Chernikoff, USA Today
This article originally appeared on Palm Beach Post: JCPenney sells 119 stores for $947 million. See Florida, US locations
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
5 hours ago
- Business Upturn
Top Q1 results today, August 1: ITC, Adani Power, Godrej Properties, Tata Power and more to announce earnings
By Aman Shukla Published on August 1, 2025, 08:09 IST Several key Indian companies, including ITC Ltd, Adani Power Ltd, Godrej Properties Ltd, UPL Ltd, and Tata Power Company Ltd, are set to release their financial results for the first quarter of FY26 on Thursday, August 1, 2025. In total, 96 firms are scheduled to announce their earnings today. Major Companies Releasing Q1 Results Today (August 1, 2025): ITC Ltd Adani Power Ltd Godrej Properties Ltd UPL Ltd Tata Power Company Ltd Tube Investments of India Ltd LIC Housing Finance Ltd GlaxoSmithKline Pharmaceuticals Ltd Multi Commodity Exchange of India Ltd Narayana Hrudayalaya Ltd Honeywell Automation Ltd Delhivery Ltd Ratnamani Metals and Tubes Ltd Capri Global Capital Ltd Graphite India Ltd Kirloskar Brothers Ltd Alivus Life Sciences Ltd G R Infraprojects Ltd JK Lakshmi Cement Ltd Shakti Pumps (India) Ltd PC Jeweller Ltd Shriram Pistons & Rings Ltd Ramkrishna Forgings Ltd Safari Industries (India) Ltd Jupiter Life Line Hospitals Ltd Healthcare Global Enterprises Ltd Dhanuka Agritech Ltd Symphony Ltd Aditya Vision Ltd Digitide Solutions Ltd RPSG Ventures Ltd Privi Speciality Chemicals Ltd Procter and Gamble Health Ltd Go Fashion India Ltd Gujarat Themis Biosyn Ltd Steel Strips Wheels Ltd Taj GVK Hotels & Resorts Ltd Sangam (India) Ltd Baazar Style Retail Ltd Hester Biosciences Ltd Century Enka Ltd Pudumjee Paper Products Ltd Kabra Extrusion Technik Ltd Themis Medicare Ltd Jay Bharat Maruti Ltd Shree Ganesh Remedies Ltd Venus Remedies Ltd Mangalam Worldwide Ltd Advani Hotels and Resorts (India) Ltd Lyka Labs Ltd Kaycee Industries Ltd Brand Concepts Ltd Sah Polymers Ltd Tilak Ventures Ltd Standard Industries Ltd Maral Overseas Ltd Odigma Consultancy Solutions Ltd Standard Capital Market Ltd Cinevista Ltd Warren Tea Ltd Starlog Enterprises Ltd Dutron Polymers Ltd Divyashakti Ltd Aro Granite Industries Ltd Next Mediaworks Ltd Sarthak Industries Ltd Sarup Industries Ltd Maris Spinners Ltd Narendra Properties Ltd Cochin Malabar Ltd Vanta Bioscience Ltd Link Pharmachem Ltd Stanrose Mafatlal Investment and Finance Ltd Enbee Trade & Finance Ltd Raw Edge Industrial Solutions Ltd Heads UP Ventures Ltd Shivamshree Businesses Ltd FGP Ltd Deccan Polypacks Ltd Investors are closely watching these announcements for revenue performance, profit trends, forward-looking statements, and management commentary. These elements are likely to influence share price movements and help investors assess near-term opportunities or risks. Ahmedabad Plane Crash Adani PowerGodrej PropertiesITCTata Power Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Wall Street Journal
8 hours ago
- Wall Street Journal
Georgia University System Can't Move Dorm Operator's Bankruptcy Case From Delaware
A bankruptcy judge denied the University System of Georgia's request to transfer the chapter 11 case of its student housing operating partner to Georgia from Delaware. Judge Laurie Selber Silverstein of the U.S. Bankruptcy Court in Wilmington, Del., said in her bench ruling on Thursday that Delaware is the proper venue for the chapter 11 filing of the Georgia subsidiary of military and student housing company Corvias because of the unit's incorporation in Delaware.
Business Upturn
14 hours ago
- Business Upturn
Global Dermal Fillers Market is Predicted to Reach ~USD 12 Billion by 2032
By GlobeNewswire Published on July 31, 2025, 22:00 IST New York, USA, July 31, 2025 (GLOBE NEWSWIRE) — Global Dermal Fillers Market is Predicted to Reach ~USD 12 Billion by 2032 | DelveInsight The demand for dermal fillers is influenced by several major factors. First, the global increase in cosmetic procedures is largely driven by an aging population and a heightened desire to preserve a youthful look, coupled with growing aesthetic awareness. Additionally, there is a notable trend toward minimally invasive cosmetic treatments because they offer greater convenience, quicker recovery, and lower costs compared to traditional surgical options. DelveInsight's Dermal Fillers Market Insights report provides the current and forecast market analysis, individual leading dermal fillers companies' market shares, challenges, dermal fillers market drivers, barriers, trends, and key market dermal fillers companies in the market. Key Takeaways from the Dermal Fillers Market Report As per DelveInsight estimates, North America is anticipated to dominate the global dermal fillers market during the forecast period. In the material segment of the dermal fillers market, the hyaluronic acid (HA) category accounted for the largest market share in 2024. Notable dermal fillers companies such as AbbVie Inc., Galderma, Merz Pharma, Tiger BioSciences, Teoxane SA, Crown Laboratories, Inc., Prollenium Medical Technologies, Inc., Johnson & Johnson Services, Inc., Anika Therapeutics, Inc., Fillmed, VIVACY Laboratories, Sinclair, Medytox, HUGEL, Inc., Ipsen Pharma, Evolus, Inc., Symatese, LG Chem, KORU Pharma Co., LTD., BIOPLUS CO., LTD., and several others are currently operating in the Dermal Fillers market. and several others are currently operating in the Dermal Fillers market. In February 2025, Crown Laboratories, Inc., a privately held global leader in skincare innovation, announced the successful acquisition of Revance Therapeutics, Inc., a pioneering biotechnology company specializing in dermal fillers. Through this acquisition, Crown significantly enhanced its product portfolio and expanded its global presence in the dermal fillers market, particularly with RHA Redensity™ and its range of RHA® 2, RHA® 3, and RHA® 4-based dermal fillers. a privately held global leader in skincare innovation, announced the successful acquisition of Revance Therapeutics, Inc., a pioneering biotechnology company specializing in dermal fillers. Through this acquisition, Crown significantly enhanced its product portfolio and expanded its global presence in the dermal fillers market, particularly with RHA Redensity™ and its range of RHA® 2, RHA® 3, and RHA® 4-based dermal fillers. In October 2024, Allergan Aesthetics, an AbbVie company, announced the national availability of JUVÉDERM® VOLUMA® XC for the treatment of temple hollowing. This hyaluronic acid (HA) filler is approved for addressing moderate to severe temple hollowing in adults over 21. As the leading HA dermal filler brand preferred by both patients and providers, the JUVÉDERM® Collection of Fillers now offers the broadest range of treatment indications to help patients achieve their aesthetic goals. To read more about the latest highlights related to the dermal fillers market, get a snapshot of the key highlights entailed in the Global Dermal Fillers Market Report Dermal Fillers Overview Dermal fillers are injectable substances used to restore volume, smooth out wrinkles, and enhance facial contours. Composed primarily of hyaluronic acid, calcium hydroxylapatite, poly-L-lactic acid, or polymethylmethacrylate beads, these fillers work by replenishing lost volume in the skin and stimulating collagen production. They are commonly used to treat areas such as the cheeks, lips, nasolabial folds, and under-eye hollows, providing a non-surgical alternative for facial rejuvenation. The effects of dermal fillers are temporary, lasting anywhere from six months to two years, depending on the type of filler and individual patient factors. The procedure is minimally invasive, typically performed in a clinical setting with little to no downtime. Local anesthesia or numbing agents may be applied to minimize discomfort during injection. While generally safe when administered by trained professionals, dermal fillers can have side effects, including swelling, bruising, redness, and in rare cases, complications like vascular occlusion or infection. Due to these risks, proper patient assessment and adherence to safety protocols are essential. Increasingly popular for their convenience and effectiveness, dermal fillers remain a leading option in cosmetic dermatology for individuals seeking subtle yet noticeable aesthetic improvements. Dermal Fillers Market Insights North America is expected to dominate the dermal fillers market in the coming years, supported by several critical factors. This leadership is largely driven by the growing number of cosmetic procedures, which are influenced by an aging population and a strong desire to maintain youthful looks. Additionally, the preference for minimally invasive aesthetic treatments, combined with a robust healthcare infrastructure, has accelerated market expansion. Rising awareness and widespread acceptance of cosmetic enhancements further reinforce this trend. Moreover, frequent product approvals and new launches from leading players continue to strengthen North America's market position. These dynamics are anticipated to maintain the region's dominance throughout the forecast period of 2025–2032. A key growth driver in the region is the increasing volume of aesthetic procedures, reflecting the rising demand for non-surgical treatments that deliver quick results with minimal recovery time. This surge is fueled by greater awareness, societal acceptance of cosmetic improvements, and a growing elderly population seeking effective anti-aging solutions. In addition, major industry players are actively investing in R&D to develop advanced dermal filler products tailored for regional needs. For instance, in June 2023, Galderma received FDA approval for Restylane® Eyelight, specifically designed to treat under-eye hollows in adults over 21. It is the first and only HA filler in the U.S. featuring NASHA® Technology to restore under-eye volume and deliver natural results. Similarly, in February 2022, Allergan Aesthetics, an AbbVie company, secured FDA approval for JUVÉDERM® VOLBELLA® XC for treating infraorbital hollows in adults over 21. This product also serves as a lip augmentation solution and helps correct perioral lines, enhancing overall facial aesthetics. Together, the growing demand for cosmetic procedures and strategic product innovations are fueling the dermal fillers market in North America, solidifying its status as a leading region in the global market. To know more about why North America is leading the market growth in the dermal fillers market, get a snapshot of the Dermal Fillers Market Outlook Dermal Fillers Market Dynamics The dermal fillers market is experiencing significant growth, driven primarily by the increasing demand for minimally invasive aesthetic procedures. Rising awareness about cosmetic enhancements and the desire for youthful appearances have fueled the adoption of dermal fillers across various demographics. Factors such as the aging global population, especially in developed economies, and growing disposable incomes in emerging markets have further contributed to market expansion. These procedures are preferred for their relatively quick recovery time and non-surgical nature, which aligns with the current trend toward less invasive treatment options. Technological advancements in dermal filler products have also played a crucial role in shaping market dynamics. Innovations in filler composition, including the introduction of hyaluronic acid-based and biostimulatory fillers, have improved safety profiles, longevity, and natural results. Moreover, ongoing research and development efforts by key players to develop fillers with longer-lasting effects and fewer side effects continue to enhance product appeal. These advancements have not only expanded the scope of applications but have also increased patient satisfaction, encouraging repeat procedures and contributing to market growth. Regulatory approvals and favorable reimbursement policies in certain regions further support the expansion of the dermal fillers market. However, stringent regulations in countries with established healthcare systems can act as barriers for new entrants. Additionally, the rise of medical tourism in countries like Thailand, India, and Mexico has created new growth opportunities for service providers and manufacturers, as patients seek affordable yet high-quality aesthetic treatments. Despite these positive trends, the dermal fillers market faces challenges such as the risk of complications, including allergic reactions and improper injections leading to vascular occlusion. Additionally, the availability of counterfeit or substandard products in some markets poses safety concerns and threatens consumer confidence. Competition from alternative aesthetic procedures like botulinum toxin injections and energy-based devices also adds pressure to the market. Nevertheless, continuous innovation, increasing social acceptance, and the growing influence of social media on beauty standards are expected to sustain robust growth in the coming years. Get a sneak peek at the dermal fillers market dynamics @ Dermal Fillers Market Trends Report Metrics Details Coverage Global Study Period 2022–2032 Dermal Fillers Market CAGR ~8% Dermal Fillers Market Size by 2032 ~USD 12 Billion Key Dermal Fillers Companies AbbVie Inc., Galderma, Merz Pharma, Tiger BioSciences, Teoxane SA, Crown Laboratories, Inc., Prollenium Medical Technologies, Inc., Johnson & Johnson Services, Inc., Anika Therapeutics, Inc., Fillmed, VIVACY Laboratories, Sinclair, Medytox, HUGEL, Inc., Ipsen Pharma, Evolus, Inc., Symatese, LG Chem, KORU Pharma Co., LTD., BIOPLUS CO., LTD., among others Dermal Fillers Market Assessment Dermal Fillers Market Segmentation Dermal Fillers Market Segmentation By Product Type: Biodegradable Fillers and Non-Biodegradable Fillers Dermal Fillers Market Segmentation By Route of Material: Hyaluronic Acid (HA), Calcium hydroxylapatite (CaHA), Poly-L-lactic acid (PLLA), Polymethylmethacrylate (PMMA), and Others Dermal Fillers Market Segmentation By Route of Gender: Male and Female Dermal Fillers Market Segmentation By End-User: Hospitals, Dermatology Clinics, and Others Dermal Fillers Market Segmentation By Geography : North America, Europe, Asia-Pacific, and Rest of World Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View Which MedTech key players in the dermal fillers market are set to emerge as the trendsetter explore @ Dermal Fillers Analysis Table of Contents 1 Dermal Fillers Market Report Introduction 2 Dermal Fillers Market Executive Summary 3 Competitive Landscape 4 Regulatory Analysis 5 Dermal Fillers Market Key Factors Analysis 6 Dermal Fillers Market Porter's Five Forces Analysis 7 Dermal Fillers Market Layout 8 Dermal Fillers Market Company and Product Profiles 9 KOL Views 10 Project Approach 11 About DelveInsight 12 Disclaimer & Contact Us Interested in knowing the dermal fillers market by 2032? Click to get a snapshot of the Dermal Fillers Market Analysis Related Reports Aesthetic Implants Market Aesthetic Implants Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key aesthetic implants companies, including POLYTECH Health & Aesthetics GmbH, Sientra, Inc, Surgiform Innovative Surgical Products, GC Aesthetics, Dentsply Sirona, Institut Straumann AG, AVINENT, AbbVie, Establishment Labs S.A., Mentor (Johnson & Johnson Medical Ltd), 3M, Zimmer Biomet, Alpha Aesthetics, Symatese, Integra LifeSciences, Sebbin, IDEAL IMPLANT INCORPORATED, Lattice Medical, CEREPLAS, Guangzhou Wanhe Plastic Material Co Ltd, among others. Medical Aesthetic Devices Market Medical Aesthetic Devices Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key medical aesthetic devices companies, including Johnson & Johnson, HansBioMed., AbbVie Inc., Sebbin, Sientra, Inc., POLYTECH Health & Aesthetics GmbH, Suneva Medical, Hanson Medical Inc., SurgiSil, Surgiform Technologies LLC, Alma Lasers, Candela Medical., Lumenis., Cutera., Sciton Inc, Merz Pharma GmbH & Bausch Health Companies Inc., Venus Concept., TRIA BEAUTY, Cynosure Inc., GALDERMA, among others. Aesthetic Thread Market Aesthetic Thread Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key aesthetic thread companies, including Aptos International Ltd, Intraline, Healux Corporation, Croma Pharma GambH, Les Encres Cosmetic Threads, W & O Medical Esthetics Gmbh, Hyundae Meditechh Co. Ltd., N-Finders Co., Ltd., Nova Threads, Savia medical, Metro Korea Co., Ltd., RIVER AESTHETICS, Spring Thread, RELIFE S.r.l., Sinclair, MINT™, PDO MAX, Promoitalia, EWELL Medical., illari Threads, among others. Aesthetic Lasers Market Aesthetic Lasers Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key aesthetic lasers companies, including Boston Scientific Corporation, Candela Medical, Lynton Lasers, Lutronic, Fotona, Alma Lasers, Sciton, Astanza Laser, Konmison, AMI INC., Lumibird Medical (Ellex), Cutera, biolitec® Holding GmbH & Co KG, Cartessa Aesthetics, Beagle E-Comm Private Limited, WON TECH Co., Ltd., Attikouris Enterprises Ltd., Aftab Forouzan Aria Company, SL LASERS, Reveal Lasers LLC, among others. Energy-Based Aesthetic Devices Market Energy-Based Aesthetic Devices Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key energy-based aesthetic devices companies, including Alma Lasers, Candela Medical, Lumenis, Cutera, Hologic Inc., Sciton Inc., Merz Pharma GmbH & Bausch Health Companies Inc., Venus Concept, TRIA BEAUTY, Cynosure Inc., SharpLight Technologies Inc., Lutronic, Fotona, among others. DelveInsight's Pharma Competitive Intelligence Service: Through its CI solutions, DelveInsight provides its clients with real-time and actionable intelligence on their competitors and markets of interest to keep them stay ahead of the competition by providing insights into the latest therapeutic area-specific/indication-specific market trends, in emerging drugs, and competitive strategies. These services are tailored to the specific needs of each client and are delivered through a combination of reports, dashboards, and interactive presentations, enabling clients to make informed decisions, mitigate risks, and identify opportunities for growth and expansion. Other Business Pharmaceutical Consulting Services Healthcare Conference Coverage Pipeline Assessment Healthcare Licensing Services Discover how a mid-pharma client gained a level of confidence in their soon-to-be partner for manufacturing their therapeutics by downloading our Due Diligence Case Study About DelveInsight DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
